Stock in Focus: Brokerage firm has been reported on several shares amidst the merged business mixed in the stock market. In this report, brokerage has given information about the stock rating and target price. We will give you information about all these shares below.
Aurobindo Pharma
Brokerage firm UBS gave SELL rating to Aurobindo Pharma shares and set the target price of Rs 1,333 per share. This is about 12 percent more than the current share price. Brokerage said the company’s quarterly results have been better than estimated. In such a situation, the stock may rise further.
Indus towers
Brokerage firm CITI has advised to buy Indus Tower’s stock. Brokerage said the company recently took over 16,100 towers from Airtel and Hexacom. This will strengthen the company’s capital structure. Brokeed has fixed the target price of Indus Tower at Rs 490 per share.
BSE (BSE)
Brokerage firm Jefferies advised the stock exchange BSE share to hold hold and set the target price of Rs 5,250. At the same time, Goldman Sachs rated the BSE share “Neutral” with a target price of Rs 5,650. The firm believes that the quarterly results did not get better than expected due to much contribution to SGF (Settlement Guarantee Fund).
State Bank of India (SBI)
There is a mixed opinion of the brokerage firm regarding the shares of State Bank of India. Brokerage firm HSBC gave a hold rating to SBI shares and the target price was Rs 800. At the same time, Morgan Stanley gave the stock a rating “Equal Weight” and the new target price of the stock fixed Rs 865. At the same time, brokerage firm Nomura advised to buy the stock and the target price increased to Rs 1,000.